• Zydus Lifesciences board meeting on May 19, 2026 to approve Q4/FY26 results and recommend final dividend.
• Trading window closed for insiders from May 8 until May 21, 2026, reopening on May 22, 2026.
• Disclosure made pursuant to SEBI Listing Regulations Regulation 29(1) requirements.